#154757

Anti-Carcinoma associated [175F11]

Cat. #154757

Anti-Carcinoma associated [175F11]

Cat. #: 154757

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Carcinoma-associated

Class: Monoclonal

Application: IHC

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Netherlands Cancer Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Carcinoma associated [175F11]
  • Research fields: Cancer
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC
  • Description: Originally raised against the human mammary carcinoma cell line (ZR-75-1), reacts with a carcinoma-associated antigen in both adenocarcinomas and squamous cell carcinomas of different origins.
  • Immunogen: Immunized with EDTA treated Human mammary carcinoma cell line (ZR-75-1)
  • Isotype: IgG2a
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Carcinoma-associated
  • Target background: Originally raised against the human mammary carcinoma cell line (ZR-75-1), reacts with a carcinoma-associated antigen in both adenocarcinomas and squamous cell carcinomas of different origins.

Applications

  • Application: IHC

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Balm et al. 1992. Eur Arch Otorhinolaryngol. 249(5):237-42. PMID: 1524802.